Bone density is decreassed in the untreated child with JDM and associated with an increased RANKL:osteoprotegerin ratio [23]; lipodystrophy is also a consequence of the JDM inflammatory process [24]. The gene discussed is TNFRSF11B; the disease is juvenile dermatomyositis.